Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?
A leap forward in standardizing the regenerative medicine supply chain
Date: June 15-17, 2023
Location: Philadelphia, Pennsylvania
Date: June 3-6, 2023
Location: Queensland, Australia
When it comes to choosing a cell and gene therapy shipping partner, not all providers are created equal. To select the best partner for your organization, it’s important to consider how their solutions will meet your needs for today and in the future.
Cryoport Systems has extended its expertise in temperature-controlled supply chain solutions with vein-to-vein BioServices offerings. BioServices expands our supply chain solutions in order to better serve our expanding clientele and the greater cell and gene industry.
©2023 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC